{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:37:58Z","timestamp":1787999878498,"version":"build-2784847793"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.clinph.2019.03.035","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T08:27:32Z","timestamp":1557390452000},"page":"1440-1445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy"],"prefix":"10.1016","volume":"130","author":[{"given":"Xi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Haggiagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathia","family":"Tzatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Santomasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2019.03.035_b0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mus.880120602","article-title":"Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features","volume":"12","author":"Albers","year":"1989","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2019.03.035_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1941874418778957","article-title":"Miller fisher syndrome associated with immunotherapy for metastatic melanoma","volume":"8","author":"Baird-Gunning","year":"2018","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.clinph.2019.03.035_b0015","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s10637-011-9787-1","article-title":"Severe meningo-radiculo-neuritis associated with ipilimumab","volume":"30","author":"Bompaire","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.clinph.2019.03.035_b0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNP.0b013e3182767d3b","article-title":"Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer","volume":"30","author":"Chen","year":"2013","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2019.03.035_b0025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mus.880131002","article-title":"AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography","volume":"13","author":"Donofrio","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2019.03.035_b0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CJI.0b013e31827807dd","article-title":"A severe case of ipilimumab-induced guillain-barre syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis","volume":"36","author":"Gaudy-Marqueste","year":"2013","journal-title":"J Immunother"},{"key":"10.1016\/j.clinph.2019.03.035_b0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2019.03.035_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cbpa.2018.05.006","article-title":"Recent progress in therapeutic antibodies for cancer immunotherapy","volume":"44","author":"Lee","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.clinph.2019.03.035_b0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/neuonc\/nou001","article-title":"Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma","volume":"16","author":"Liao","year":"2014","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.clinph.2019.03.035_b0050","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0000000000004359","article-title":"Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan","volume":"89","author":"Suzuki","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2019.03.035_b0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CJI.0000000000000070","article-title":"Peripheral neuropathy associated with ipilimumab: a report of 2 cases","volume":"38","author":"Thaipisuttikul","year":"2015","journal-title":"J Immunother"},{"key":"10.1016\/j.clinph.2019.03.035_b0060","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1212\/WNL.0000000000006124","article-title":"Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer","volume":"91","author":"Touat","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2019.03.035_b0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","article-title":"Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"29","author":"Van den Bergh","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2019.03.035_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053745","article-title":"The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network","volume":"8","author":"Voskens","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.clinph.2019.03.035_b0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/annonc\/mdr028","article-title":"Anti-CTLA-4 antibody-induced Guillain-Barre syndrome in a melanoma patient","volume":"22","author":"Wilgenhof","year":"2011","journal-title":"Ann Oncol"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245719307461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245719307461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:53:53Z","timestamp":1761393233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245719307461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1388245719307461"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2019.03.035","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2019.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}